Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Colorado Gathers Stakeholder Feedback for Rulemaking Updates

Impacted items would include pharmacy and topical reimbursement, home health, prior authorization, and more.

Read More →

August 10, 2026

Access to Care Claims Procedures

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.

Read More →

August 3, 2026

Advocacy Opportunity Cost Containment Treatment Guidelines

Texas Seeks Input on Draft for Topical Analgesic Audit

Stakeholder feedback for the audit plan will be accepted until 5:00 PM CST on August 6th.

Read More →

August 3, 2026

Access to Care Treatment Guidelines

CHSWC Releases 2025 Annual Report

Recommendations from the California report touched on pharmacy topics and access to care.

Read More →

August 3, 2026

Worker Safety

Congressional Bill to Remove Federal Heat Standards Advances

If enacted, OSHA would be prevented from adopting heat protection standards proposed in 2024, or any substantially similar rule.

Read More →

August 3, 2026

Ancillary Services Claim Data

WCRI Reports on Trends in Non-Price-Controlled Medical Services

The study focused on DME and professional services billed by nonhospital providers from January 1, 2010 through June 30, 2025.

Read More →

August 3, 2026

Advocacy Opportunity Treatment Guidelines

Pennsylvania Advisory Council Provides Pharmacy and Study Updates

The meeting discussed issues that could affect pharmacy reimbursement, statutory provider definitions, and medical accessibility reporting.

Read More →

July 27, 2026

Advocacy Opportunity Claims Procedures

Texas DWC Stakeholder Meeting

Topics covered include a new AI innovation office, a remote interpreters program, and updates for rulemaking and audits.

Read More →

July 27, 2026

Claim Costs Pharmacy Data

Generic Drug Tariffs Proposed for 2028

A 100% tariff is expected to take place August 1, 2028 for generic drugs imported into the U.S., followed by a 200% tariff in August 2029.

Read More →

July 27, 2026

« Previous 1 2 3 4 … 60 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduced significant implications for clinical research, drug development, and downstream utilization.

State of the Nation: Summer 2026

Healthesystems’ Sandy Shtab examines key workers’ comp policy trends, from PBM regulation and AI oversight to marijuana rescheduling and injured worker engagement.